المؤلفون: Miyake M; Department of Urology, Nara Medical University, Kashihara, Japan., Nishimura N; Department of Urology, Nara Medical University, Kashihara, Japan., Nakahama T; Department of Urology, Nara Medical University, Kashihara, Japan., Nishimoto K; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Oyama M; Department of Urology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan., Matsushita Y; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Miyake H; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan., Fukuhara H; Department of Urology, Kochi Medical School, Nankoku, Japan., Inoue K; Department of Urology, Kochi Medical School, Nankoku, Japan., Kobayashi K; Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan., Matsuyama H; Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, Japan.; Department of Urology, JA Yamaguchi Kouseiren Nagato General Hospital, Nagato, Japan., Fujii T; Department of Diagnostic Pathology, Nara Medical University, Kashihara, Japan.; Division of Fostering Required Medical Human Resources, Center for Infectious Disease Education and Research (CiDER), Osaka University, Osaka, Japan., Hirao Y; Department of Urology, Osaka Gyoumeikan Hospital, Konohana-ku, Japan., Fujimoto K; Department of Urology, Nara Medical University, Kashihara, Japan.

المصدر: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Aug; Vol. 31 (8), pp. 876-885. Date of Electronic Publication: 2024 Apr 30.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/surgery , Urinary Bladder Neoplasms*/mortality , Cystectomy*/methods , Neoplasm Recurrence, Local*/epidemiology , Neoplasm Recurrence, Local*/prevention & control , Neoplasm, Residual*, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Neoplasm Invasiveness ; Aged, 80 and over ; Propensity Score ; Progression-Free Survival ; Disease Progression ; Reoperation/statistics & numerical data ; Urinary Bladder/pathology ; Urinary Bladder/surgery ; Non-Muscle Invasive Bladder Neoplasms

المؤلفون: Balboa-Barreiro V; Universidade da Coruña, Rheumatology and Health Research Group, Department of Health Sciences, Faculty of Nursing and Podiatry, Esteiro, 15403 Ferrol, Spain; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain., Pértega-Díaz S; Universidade da Coruña, Rheumatology and Health Research Group, Department of Health Sciences, Faculty of Nursing and Podiatry, Esteiro, 15403 Ferrol, Spain; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain. Electronic address: s.pertega@udc.es., García-Rodríguez T; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain., González-Martín C; Universidade da Coruña, Rheumatology and Health Research Group, Department of Health Sciences, Faculty of Nursing and Podiatry, Esteiro, 15403 Ferrol, Spain; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain., Pardeiro-Pértega R; Digestive System Department, Complexo Hospitalario Universitario A Coruña, Xubias de Arriba 84, 15006 A Coruña, Spain., Yáñez-González-Dopeso L; Digestive System Department, Complexo Hospitalario Universitario A Coruña, Xubias de Arriba 84, 15006 A Coruña, Spain., Seoane-Pillado T; Universidade da Coruña, Rheumatology and Health Research Group, Department of Health Sciences, Faculty of Nursing and Podiatry, Esteiro, 15403 Ferrol, Spain; Instituto de Investigación Biomédica de A Coruña (INIBIC), Nursing and Health Care Research Group, Xubias de Arriba 84, 15006 A Coruña, Spain.

المصدر: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2024 Jul; Vol. 56 (7), pp. 1229-1236. Date of Electronic Publication: 2023 Dec 11.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3562 (Electronic) Linking ISSN: 15908658 NLM ISO Abbreviation: Dig Liver Dis Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/surgery , Colorectal Neoplasms*/mortality , Colorectal Neoplasms*/pathology , Neoplasm Recurrence, Local*/epidemiology , Neoplasm Recurrence, Local*/mortality, Humans ; Male ; Aged ; Female ; Middle Aged ; Risk Factors ; Follow-Up Studies ; Prognosis ; Incidence ; Aged, 80 and over ; Neoplasm Staging ; Proportional Hazards Models

المؤلفون: Mateo-Kubach P; Gynecology, Hospital Universitario de Toledo, Toledo, Toledo, Spain paulagmateo@gmail.com., Ramirez PT; Department of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, Texas, USA., Pareja R; Gynecology, Gynecologic Oncology, Clinica Astorga, Medellín, and Instituto Nacional de Cancerología, Bogotá, Colombia., Deavers M; Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA., Farach AM; Radiation Oncology Group, Houston Methodist Hospital, Houston, Texas, USA.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Jun 03; Vol. 34 (6), pp. 946-950. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Neoplasms*/diagnosis , Uterine Neoplasms*/pathology , Uterine Neoplasms*/therapy , Sarcoma*/diagnosis , Sarcoma*/therapy , Sarcoma*/pathology , Neoplasm Recurrence, Local*/diagnosis , Neoplasm Recurrence, Local*/pathology, Humans ; Female ; Middle Aged ; Neoplasm Grading

المؤلفون: Maas SLN; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Hielscher T; Department of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sievers P; Department of Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany., Hovestadt V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Suwala AK; Department of Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany., Acker T; Institute of Neuropathology, Justus-Liebig-University, Gießen, Germany., Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Herold-Mende C; Division of Experimental Neurosurgery, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany., Wick W; Clinical Cooperation Unit Neurooncology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., von Deimling A; Department of Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany., Berghaus N; Department of Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany., Sahm F; Department of Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany. Felix.Sahm@med.uni-heidelberg.de.

المصدر: Acta neuropathologica [Acta Neuropathol] 2024 Aug 08; Vol. 148 (1), pp. 17. Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE

مواضيع طبية MeSH: Meningioma*/genetics , Meningioma*/pathology , Chromosomes, Human, Pair 1*/genetics , Meningeal Neoplasms*/genetics , Meningeal Neoplasms*/pathology , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/pathology, Humans ; Female ; Male ; Middle Aged ; Aged ; Chromosome Deletion ; Adult

المؤلفون: Guo G; Department of Neurosurgery, Juha International Center for Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China., Zhang Z; Department of Neurosurgery, Juha International Center for Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China., Zhang J; Department of Neurosurgery, Juha International Center for Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China., Wang D; Department of Cerebrovascular Disease, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, China., Xu S; Department of Neurosurgery, Juha International Center for Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China., Liu G; Department of Neurosurgery, Juha International Center for Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China., Gao Y; Department of Neurosurgery, Juha International Center for Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China., Mei J; Department of Neurosurgery, Juha International Center for Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China., Yan Z; Department of Neurosurgery, Juha International Center for Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China., Zhao R; Department of Pathology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, China., Wang M; Department of Radiology, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, China., Li T; Henan Provincial Neurointerventional Engineering Research Center, Henan International Joint Laboratory of Cerebrovascular Disease, Henan Engineering Research Center of Cerebrovascular Intervention Innovation, Zhengzhou, Henan, China.; Department of Cerebrovascular Disease, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Henan University People's Hospital, Zhengzhou, Henan, China., Bu X; Department of Neurosurgery, Juha International Center for Neurosurgery, Glioma Clinical Diagnosis and Treatment Center of Henan Province, Glioma Engineering Research Center for Precision Diagnosis and Treatment of Henan Province, Zhengzhou University People's Hospital, Zhengzhou, 450003, Henan, China. xingyaob@zzu.edu.cn.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Aug 06; Vol. 73 (10), pp. 193. Date of Electronic Publication: 2024 Aug 06.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/drug therapy , Glioblastoma*/genetics , Bevacizumab*/therapeutic use , Bevacizumab*/administration & dosage , Circulating Tumor DNA*/genetics , Circulating Tumor DNA*/blood , Immune Checkpoint Inhibitors*/therapeutic use , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/genetics , Brain Neoplasms*/drug therapy , Brain Neoplasms*/genetics, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor/genetics ; Prognosis

المؤلفون: O'Hare P; Department of Paediatric Oncology, Royal Belfast Hospital for Sick Children, Northern Ireland, UK., Cooney T; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Broad Institute, Cambridge, Massachusetts, USA.; Day One Biopharmaceuticals, Boston, Massachusetts, USA., de Blank P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Broad Institute, Cambridge, Massachusetts, USA.; University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA., Kieran M; Day One Biopharmaceuticals, Boston, Massachusetts, USA., Milde T; Clinical Pediatric Oncology, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Fangusaro J; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA., Fisher M; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Avula S; Department of Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK., Packer R; Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, District of Columbia, USA., Fukuoka K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan., Mankad K; Department of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, Department of Radiology, London, UK., Mueller S; Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, San Francisco, California, USA., Waanders AJ; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Opocher E; Paediatric Haematology, Oncology and Stem Cell Transplant Division, Padua University Hospital, Padua, Italy., Bouffet E; The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., Raabe E; Division of Pediatric Oncology, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Werle NE; Pediatric Onco-Hematology Department, University Hospital of Strasbourg. UMR CNRS 7021, University of Strasbourg, Strasbourg, France., Azizi AA; Department of Pediatrics and Adolescent Medicine and Comprehensive Centre of Pediatrics, Medical University of Vienna, Vienna, Austria., Robison NJ; Division of Hematology & Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA., Hernáiz Driever P; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, German HIT-LOGGIC-Registry for LGG in children and adolescents, Department of Pediatric Oncology/Hematology, Berlin, Germany., Russo M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Schouten N; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands., van Tilburg CM; Clinical Pediatric Oncology, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Sehested A; Department of Paediatrics and Adolescent Medicine, The University Hospital Rigshospitalet, Copenhagen, Denmark., Grill J; Department of Pediatric and Adolescent Oncology, Villejuif, France., Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Broad Institute, Cambridge, Massachusetts, USA., Kilday JP; The Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer Sciences, University of Manchester, and Royal Manchester Children's Hospital, Manchester, UK., Witt O; Clinical Pediatric Oncology, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Ashley DM; Department of Neurosurgery, The Preston Robert Tisch Brain Tumor Center. Pediatric Neuro-Oncology, Preuss Laboratory for Brain Tumor Research, Durham, North Carolina, USA., Ertl-Wagner BB; Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada., Tabori U; The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., Hargrave DR; UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital for Children, London, UK.

المصدر: Neuro-oncology [Neuro Oncol] 2024 Aug 05; Vol. 26 (8), pp. 1357-1366.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Glioma*/drug therapy , Glioma*/pathology , Brain Neoplasms*/drug therapy , Brain Neoplasms*/pathology , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/pathology , Drug Resistance, Neoplasm* , Consensus* , Delphi Technique*, Humans ; Child ; Protein Kinase Inhibitors/therapeutic use ; Neoplasm Grading

المؤلفون: Salani R; Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, California, USA rsalani@mednet.ucla.edu., McCormack M; Department of Oncology, University College London Hospitals, London, UK., Kim YM; Gynecologic Cancer Center, Asan Cancer Institute, Asan Medical Center, University of Ulsan, Seoul, Korea (the Republic of)., Ghamande S; Georgia Cancer Center, Augusta University, Augusta, Georgia, USA., Hall SL; National Cervical Cancer Coalition, Research Triangle Park, North Carolina, USA., Lorusso D; Gynecologic Oncology Unit, Fondazione Policlinico Gemelli IRCCS and Catholic University of the Sacred Heart, Rome, Italy., Barraclough L; Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Gilbert L; The Gerald Bronfman Department of Oncology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Guzman Ramirez A; Instituto de Investigación en Ciencias Médicas (ICIMED), San José, Costa Rica., Lu CH; Department of OB/GYN, Taichung Veterans General Hospital, Taichung, Taiwan., Sabatier R; Department of Medical Oncology, Aix-Marseille University, CRCM, Inserm, CNRS, Institut Paoli-Calmettes, Marseille, France., Colombo N; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.; Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, Italy., Hu Y; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Krishnan V; Genentech, Inc, South San Francisco, California, USA., Molinero L; Genentech, Inc, South San Francisco, California, USA., Feng Y; Genentech, Inc, South San Francisco, California, USA., Kim N; Genentech, Inc, South San Francisco, California, USA., Castro M; Genentech, Inc, South San Francisco, California, USA., Lin YG; Genentech, Inc, South San Francisco, California, USA., Monk BJ; Department of Oncology, HonorHealth University of Arizona College of Medicine and Creighton University School of Medicine, Phoenix, Arizona, USA.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Aug 05; Vol. 34 (8), pp. 1140-1148. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/drug therapy , Uterine Cervical Neoplasms*/pathology , Antibodies, Monoclonal, Humanized*/administration & dosage , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/pathology, Humans ; Female ; Middle Aged ; Adult ; Aged ; B7-H1 Antigen/metabolism ; B7-H1 Antigen/antagonists & inhibitors ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

المؤلفون: Vergote I; University Hospitals Leuven, Leuven, Belgium ignace.vergote@uz.kuleuven.ac.be.; Vlaams Instituut voor Biotechnologie, KU Leuven Center for Cancer Biology, Leuven, Belgium., Perez Fidalgo A; Medical Oncology, Hospital Clinico Universitario, Valencia, Spain.; Grupo Espanol de Investigacion en Cancer Ginecologico (GEICO), Madrid, Spain., Valabrega G; Department of Oncology, University of Turin, Turin, Italy.; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy., Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, Florida, USA.; Gynecologic Oncology Group (GOG) Foundation, Philadelphia, Pennsylvania, USA., Herzog T; Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, Ohio, USA., Cibula D; Charles University and General University Hospital in Prague, Prague, Czech Republic.; Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic., Colombo N; Gynecologic Oncology Program, European Institute of Oncology IRCCS, Milan, Italy.; Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Pothuri B; NYU Langone Health Perlmutter Cancer Center, New York, New York, USA., Sehouli J; Department of Gynecology, European Competence Center for Ovarian Cancer, Charité Comprehensive Cancer Center, Charité-Berlin University of Medicine, Berlin, Germany., Korach J; Sheba Medical Center, Tel Hashomer, Israel.; Tel Aviv University, Tel Aviv, Israel., Barlin J; Women's Cancer Care Associates, LLC, Albany, New York, USA., Papadimitriou CA; Department of Clinical Therapeutics, University of Athens School of Medicine, Athens, Greece., van Gorp T; University Hospitals Leuven, Leuven, Belgium.; Gynaecological Oncology, KU Leuven University Hospitals Leuven, Leuven, Belgium., Richardson D; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., McCarthy M; Galway University Hospitals, Galway, Ireland., Antill Y; Frankston Hospital, Frankston and Monash University, Frankston, Victoria, Australia., Mirza MR; Department of Oncology, Rigshospitalet; Copenhagen University Hospital, Copenhagen, Denmark., Li K; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Kalyanapu P; Karyopharm Therapeutics Inc, Newton, Massachusetts, USA., Slomovitz B; Florida Cancer Specialists and Research Institute, West Palm Beach, Florida, USA.; Gynecologic Oncology, Mount Sinai Medical Center, New York, New York, USA., Coleman RL; Gynecologic Oncology Group (GOG) Foundation, Prague, Czech Republic.; Texas Oncology, Shenandoah, Texas, USA.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Aug 05; Vol. 34 (8), pp. 1283-1289. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article; Clinical Trial Protocol; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Triazoles*/administration & dosage , Hydrazines*/administration & dosage , Hydrazines*/therapeutic use , Endometrial Neoplasms*/drug therapy , Endometrial Neoplasms*/pathology , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/pathology, Humans ; Female ; Double-Blind Method ; Tumor Suppressor Protein p53/genetics ; Maintenance Chemotherapy/methods ; Clinical Trials, Phase III as Topic

المؤلفون: Trozzi R; Department of Women, children and Public health sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Tuyaerts S; Laboratory of Medical and Molecular Oncology (LMMO), Department of Medical Oncology, Vrije Universiteit Brussel, UZ Brussel, Brussel, Belgium., Annibali D; Laboratory of Gynecological Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Gynecological Oncology, Antoni van Leeuwenhoek Netherlands Cancer Institute Department of Gynecology, Amsterdam, The Netherlands., Herreros Pomares A; Laboratory of Gynecological Oncology, Department of Oncology, KU Leuven, Leuven, Belgium., Boog L; Department of Gynecological Oncology, Antoni van Leeuwenhoek Netherlands Cancer Institute Department of Gynecology, Amsterdam, The Netherlands., Van Dam P; Division Gynaecological Oncology, Multidisciplinary oncologic Centre, CORE Antwerp University, Edegem, Belgium., Leunen K; Gynecology and Obstetrics, AZ Sint-Maarten, Mechelen, Antwerpen, Belgium., Deroose C; Nuclear Medicine, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium.; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Flanders, Belgium., Trum H; Department of Gynecological Oncology, Antoni van Leeuwenhoek Netherlands Cancer Institute Department of Gynecology, Amsterdam, The Netherlands., Amant F; Laboratory of Gynecological Oncology, Department of Oncology, KU Leuven, Leuven, Belgium frederic.amant@uzleuven.be.; Department of Gynecological Oncology, Antoni van Leeuwenhoek Netherlands Cancer Institute Department of Gynecology, Amsterdam, The Netherlands.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Aug 05; Vol. 34 (8), pp. 1217-1224. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Fulvestrant*/administration & dosage , Fulvestrant*/therapeutic use , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/pathology , Neoplasm Recurrence, Local*/metabolism , Receptors, Estrogen*/metabolism, Humans ; Female ; Middle Aged ; Prospective Studies ; Adult ; Aged ; Antineoplastic Agents, Hormonal/therapeutic use ; Antineoplastic Agents, Hormonal/administration & dosage ; Genital Neoplasms, Female/drug therapy ; Genital Neoplasms, Female/pathology ; Genital Neoplasms, Female/metabolism ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/metabolism ; Sex Cord-Gonadal Stromal Tumors/drug therapy ; Sex Cord-Gonadal Stromal Tumors/pathology

المؤلفون: Cheng Y; Department of Laboratory Medicine, Yan'an Hospital of Kunming City, Yunnan Cardiovascular Hospital, Kunming, Yunan, China., Zhu G; Department of Clinical Laboratory, The First People's Hospital of Huzhou, Huzhou, Zhejiang, China. Electronic address: zhugejing123@163.com.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Aug; Vol. 19 (8), pp. e19.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Thymoma*/surgery , Thymoma*/mortality , Thymoma*/pathology , Thymus Neoplasms*/surgery , Thymus Neoplasms*/mortality , Thymus Neoplasms*/pathology , Neoplasm Recurrence, Local*/pathology , Neoplasm Recurrence, Local*/surgery , Neoplasm Recurrence, Local*/mortality, Humans ; Survival Rate ; Prognosis